NIKA — Nika Pharmaceuticals Share Price
0.000.00%
Last trade - 00:00- $972.93m
- $973.18m
- 26
- 22
- 43
- 20
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 6,080,814.05 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -55356.25% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Nika Pharmaceuticals, Inc. is engaged in the development and distribution of a variety of pharmaceutical products, including dietary supplements and antiviral drugs. It has the exclusive rights agreement for the production and distribution of two dietary supplements, namely Carotilen and Physiolong. Carotilen is a dietary supplement in the form of soft gelatin capsules that improves and regulates the metabolism of the epithelial cells and protects them from degenerative alterations. Physiolong is a dietary food supplement in the form of hard gelatin capsules, which serves as a general stimulant for those in a period of convalescence, as well as in situations of high mental and physical loads. It has an exclusive rights agreement for the production and distribution of Thymus Nuclear Glycoprotein (TNG). It also has the rights agreement for the production and sale of an additional six dietary supplements, such as Hypocholestin, Biodetoxin, Dry Boza, Fructin, Anthocylen C, and Silymaron.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- May 28th, 2004
- Public Since
- January 24th, 2024
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 1,026,406,001
- Address
- 2269 Merrimack Valley Avenue, HENDERSON, 89044
- Web
- https://www.nikapharmaceuticals.com/
- Phone
- +1 7023263615
- Auditors
- Boladale Lawal & CO
Upcoming Events for NIKA
Q3 2025 Nika Pharmaceuticals Inc Earnings Release
Similar to NIKA
Acusphere
Pink Sheets on Nasdaq
Agentix
Pink Sheets on Nasdaq
Agrios Global Holdings
Pink Sheets on Nasdaq
Aida Pharmaceuticals
Pink Sheets on Nasdaq
Aleafia Health
Pink Sheets on Nasdaq
FAQ
What is the Nika Pharmaceuticals share price?
As of Today at 22:17 UTC, shares in Nika Pharmaceuticals are trading at $0.95. This share price information is delayed by 15 minutes.
How has the Nika Pharmaceuticals share price performed this year?
Shares in Nika Pharmaceuticals last closed at $0.95 and the price had moved by +59.85% over the past 365 days. In terms of relative price strength the Nika Pharmaceuticals share price has outperformed the S&P500 Index by +37.73% over the past year.
What are the analyst and broker recommendations for Nika Pharmaceuticals?
There is no consensus recommendation for this security.
Find out moreWhat is the Nika Pharmaceuticals dividend yield?
Nika Pharmaceuticals does not currently pay a dividend.
Does Nika Pharmaceuticals pay a dividend?
Nika Pharmaceuticals does not currently pay a dividend.
When does Nika Pharmaceuticals next pay dividends?
Nika Pharmaceuticals does not currently pay a dividend.
How do I buy Nika Pharmaceuticals shares?
To buy shares in Nika Pharmaceuticals you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Nika Pharmaceuticals?
As of the previous close price of $0.95, shares in Nika Pharmaceuticals had a market capitalisation of $972.93m.
Where are Nika Pharmaceuticals shares listed?
Here are the trading details for Nika Pharmaceuticals:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: NIKA
What kind of share is Nika Pharmaceuticals?
Based on an overall assessment of its quality, value and momentum Nika Pharmaceuticals is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Nika Pharmaceuticals share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Nika Pharmaceuticals share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nika Pharmaceuticals. Over the past six months, its share price has underperformed the S&P500 Index by -11.9%.
As of the last closing price of $0.95, shares in Nika Pharmaceuticals were trading +10.99% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Nika Pharmaceuticals PE Ratio?
The Nika Pharmaceuticals PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.95.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Nika Pharmaceuticals?
We do not have data on Nika Pharmaceuticals' directors